|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-6-20
|
|
pubmed:abstractText |
To determine whether a relationship exists between the tumor volume (TV) or relative choline content determined using magnetic resonance spectroscopy imaging (MRSI) at 3T and the clinical prognostic parameters for patients with localized prostate cancer (PCa).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1879-355X
|
|
pubmed:author |
pubmed-author:Ben SalemDouraïedD,
pubmed-author:BonnetainFranckF,
pubmed-author:BrunotteFrançoisF,
pubmed-author:CochetAlexandreA,
pubmed-author:CormierLucL,
pubmed-author:CréhangeGillesG,
pubmed-author:Funes de la VegaMathildeM,
pubmed-author:LiegardMélanieM,
pubmed-author:MaingonPhilippeP,
pubmed-author:MirjoletCélineC,
pubmed-author:ParfaitSébastienS,
pubmed-author:WalkerPaul MPM
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
80
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1087-94
|
|
pubmed:meshHeading |
pubmed-meshheading:20615624-Aged,
pubmed-meshheading:20615624-Choline,
pubmed-meshheading:20615624-Citric Acid,
pubmed-meshheading:20615624-Creatine,
pubmed-meshheading:20615624-Humans,
pubmed-meshheading:20615624-Magnetic Resonance Spectroscopy,
pubmed-meshheading:20615624-Male,
pubmed-meshheading:20615624-Middle Aged,
pubmed-meshheading:20615624-Neoplasm Staging,
pubmed-meshheading:20615624-Polyamines,
pubmed-meshheading:20615624-Prognosis,
pubmed-meshheading:20615624-Prostate-Specific Antigen,
pubmed-meshheading:20615624-Prostatic Neoplasms,
pubmed-meshheading:20615624-Retrospective Studies,
pubmed-meshheading:20615624-Risk Assessment,
pubmed-meshheading:20615624-Tumor Burden,
pubmed-meshheading:20615624-Tumor Markers, Biological
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Centre Georges François Leclerc, Dijon, France. gcrehange@cgfl.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
